Novel piperazine core compound induces death in human liver cancer cells: possible pharmacological properties.

Samie N, Muniandy S, Kanthimathi MS, Haerian BS, Azudin RE

DOI: 10.1038/srep24172
Published: 2016 Apr 13
Container: Scientific reports
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/srep24172,
  title = {Novel piperazine core compound induces death in human liver cancer cells: possible pharmacological properties.},
  author = {Samie N and Muniandy S and Kanthimathi MS and Haerian BS and Azudin RE},
  year = {2016},
  journal = {Scientific reports},
  doi = {10.1038/srep24172},
  url = {https://doi.org/10.1038/srep24172}
}

RIS

TY  - JOUR
TI  - Novel piperazine core compound induces death in human liver cancer cells: possible pharmacological properties.
AU  - Samie N
AU  - Muniandy S
AU  - Kanthimathi MS
AU  - Haerian BS
AU  - Azudin RE
PY  - 2016
JO  - Scientific reports
DO  - 10.1038/srep24172
UR  - https://doi.org/10.1038/srep24172
ER  -

APA

N, S., S, M., MS, K., BS, H., & RE, A. (2016). Novel piperazine core compound induces death in human liver cancer cells: possible pharmacological properties.. Scientific reports. https://doi.org/10.1038/srep24172

Source records

pubmed · retrieved 2026-09-24T23:22:34.713Z